{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:05:13Z","timestamp":1792789513085,"version":"4.5.0"},"reference-count":143,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Bialystok","award":["B.SUB.26.440"],"award-info":[{"award-number":["B.SUB.26.440"]}],"id":[{"id":"https:\/\/ror.org\/00y4ya841","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Medical University of Bialystok","award":["B.SUB.26.441"],"award-info":[{"award-number":["B.SUB.26.441"]}],"id":[{"id":"https:\/\/ror.org\/00y4ya841","id-type":"ROR","asserted-by":"crossref"}]},{"award":["B.SUB.26.440"],"award-info":[{"award-number":["B.SUB.26.440"]}],"id":[{"id":"https:\/\/ror.org\/00y4ya841","id-type":"ROR","asserted-by":"publisher"}]},{"award":["B.SUB.26.441"],"award-info":[{"award-number":["B.SUB.26.441"]}],"id":[{"id":"https:\/\/ror.org\/00y4ya841","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Psoriasis is a chronic, immune-mediated inflammatory disease affecting the skin, nails, and joints. Its complex pathogenesis results from interactions between genetic susceptibility and environmental factors and is accompanied by an increased risk of multiple systemic comorbidities, particularly cardiovascular disease. Growing evidence indicates that both conditions share common molecular pathways driven by chronic inflammation, endothelial dysfunction, metabolic disturbances, and immune dysregulation. Among the emerging molecular biomarkers, chemerin, endocan, and growth differentiation factor-15 (GDF-15) have attracted considerable attention due to their role in vascular homeostasis, adipose tissue biology, glucose metabolism, and inflammatory signaling. This review summarizes current evidence on the involvement of these biomarkers in psoriasis and cardiovascular disease, highlighting their contribution to the molecular mechanisms underlying the psoriasis\u2013cardiovascular disease axis. Furthermore, we discussed their potential usefulness as candidate biomarkers for cardiovascular risk. However, prospective validation is strictly required to confirm their clinical utility and establish their incremental predictive value beyond conventional risk factors.<\/jats:p>","DOI":"10.3390\/ijms27198918","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:40:17Z","timestamp":1791596417000},"page":"8918","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular Biomarkers Linking Psoriasis and Cardiovascular Disease: Current Evidence and Clinical Perspectives"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2873-4001","authenticated-orcid":false,"given":"Mateusz","family":"Matwiejuk","sequence":"first","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Bialystok, 15-540 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1948-0545","authenticated-orcid":false,"given":"Hanna","family":"My\u015bliwiec","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Bialystok, 15-540 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4936-3120","authenticated-orcid":false,"given":"Agnieszka","family":"Mik\u0142osz","sequence":"additional","affiliation":[{"name":"Department of Physiology, Medical University of Bialystok, 15-222 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Jarocewicz","sequence":"additional","affiliation":[{"name":"Regional Centre for Transfusion Medicine, 15-950 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7407-8156","authenticated-orcid":false,"given":"Adrian","family":"Chabowski","sequence":"additional","affiliation":[{"name":"Department of Physiology, Medical University of Bialystok, 15-222 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5923-910X","authenticated-orcid":false,"given":"Iwona","family":"Flisiak","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Bialystok, 15-540 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"adv42945","DOI":"10.2340\/actadv.v105.42945","article-title":"Epidemiology of Psoriasis: A Worldwide Global Study","volume":"105","author":"Skayem","year":"2025","journal-title":"Acta Derm. Venereol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.7861\/clinmed.2021-0257","article-title":"Psoriasis: A brief overview","volume":"21","author":"Raharja","year":"2021","journal-title":"Clin. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s40257-024-00883-y","article-title":"Image-Based Artificial Intelligence in Psoriasis Assessment: The Beginning of a New Diagnostic Era?","volume":"25","author":"Goessinger","year":"2024","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Halip, I.A., Vata, D., Patrascu, A.I., Temelie Olinici, D., Popescu, I.A., Mocanu, M., Gugulus, D.L., Popa, V.T., Gheuca-Solovastru, D., and Gheuca-Solovastru, L. (2025). The Role of Dermoscopy and High-Frequency Ultrasonography in the Diagnosis and Monitoring of Psoriasis Vulgaris. Medicina, 61.","DOI":"10.3390\/medicina61111978"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Liu, L., Cui, S., Liu, M., Huo, X., Zhang, G., and Wang, N. (2022). Psoriasis Increased the Risk of Adverse Cardiovascular Outcomes: A New Systematic Review and Meta-Analysis of Cohort Studies. Front. Cardiovasc. Med., 9, Correction in Front. Cardiovasc. Med. 2022, 9, 929149. https:\/\/doi.org\/10.3389\/fcvm.2022.929149.","DOI":"10.3389\/fcvm.2022.829709"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1001\/jamadermatol.2022.3682","article-title":"Association Between Inflammatory Bowel Disease and Both Psoriasis and Psoriatic Arthritis: A Bidirectional 2-Sample Mendelian Randomization Study","volume":"158","author":"Freuer","year":"2022","journal-title":"JAMA Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Liu, K.L., Tsai, W.C., Tu, H.P., and Lee, C.H. (2020). Statin use and the risk of chronic kidney disease in patients with psoriasis: A nationwide cohort study in Taiwan. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0237816"},{"key":"ref_9","first-page":"438","article-title":"Chronic kidney disease in psoriasis: A cohort study","volume":"18","author":"Conti","year":"2020","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"16581","DOI":"10.1038\/s41598-019-53017-4","article-title":"Risk of End-Stage Renal Disease in Psoriatic Patients: Real-World Data from a Nationwide Population-Based Cohort Study","volume":"9","author":"Lee","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_11","first-page":"113","article-title":"Comorbid Psoriasis and Metabolic Syndrome: Clinical Implications and Optimal Management","volume":"12","author":"Hillary","year":"2022","journal-title":"Psoriasis"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"103577","DOI":"10.1016\/j.autrev.2024.103577","article-title":"Global prevalence of obesity in patients with psoriasis: An analysis in the past two decades","volume":"23","author":"Wang","year":"2024","journal-title":"Autoimmun. Rev."},{"key":"ref_13","first-page":"9389","article-title":"Dyslipidemia frequency in patients with plaque psoriasis: A cross-sectional study","volume":"14","author":"Farooq","year":"2025","journal-title":"J. Neonatal Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13098-025-01622-x","article-title":"Obesity mediates the association between psoriasis and diabetes incidence: A population-based study","volume":"17","author":"Xu","year":"2025","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5021\/ad.25.142","article-title":"Association Between Psoriasis Risk and Body Mass Index and Waist Circumference in Diabetes: A Population-Based Cohort Study","volume":"38","author":"Yoo","year":"2026","journal-title":"Ann. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e38007","DOI":"10.1097\/MD.0000000000038007","article-title":"Prevalence and risk of nonalcoholic fatty liver disease among adult psoriatic patients: A systematic review, meta-analysis, and trial sequential analysis","volume":"103","author":"Hu","year":"2024","journal-title":"Medicine"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jad.2023.05.059","article-title":"Evidence for a causal association between psoriasis and psychiatric disorders using a bidirectional Mendelian randomization analysis in up to 902,341 individuals","volume":"337","author":"Wang","year":"2023","journal-title":"J. Affect. Disord."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000447777","article-title":"Obesity, Type 1 Diabetes, and Psoriasis: An Autoimmune Triple Flip","volume":"84","author":"Granata","year":"2017","journal-title":"Pathobiology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"452","DOI":"10.5114\/ada.2020.96243","article-title":"Pathogenesis of psoriasis in the \u201comic\u201d era. Part III. Metabolic disorders, metabolomics, nutrigenomics in psoriasis","volume":"37","author":"Nedoszytko","year":"2020","journal-title":"Adv. Dermatol. Allergol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Brazzelli, V., Maffioli, P., Bolcato, V., Ciolfi, C., D\u2019Angelo, A., Tinelli, C., and Derosa, G. (2021). Psoriasis and Diabetes, a Dangerous Association: Evaluation of Insulin Resistance, Lipid Abnormalities, and Cardiovascular Risk Biomarkers. Front. Med., 8.","DOI":"10.3389\/fmed.2021.605691"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s13555-021-00483-2","article-title":"Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated Comorbidities","volume":"11","author":"Menter","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_22","unstructured":"World Health Organization (2025). Cardiovascular Diseases (CVDs), WHO. Available online: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds)."},{"key":"ref_23","first-page":"e563","article-title":"2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Gao, N., Kong, M., Li, X., Zhu, X., Wei, D., Ni, M., Wang, Y., Hong, Z., and Dong, A. (2022). The Association Between Psoriasis and Risk of Cardiovascular Disease: A Mendelian Randomization Analysis. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.918224"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zhao, H., Wu, J., and Wu, Q. (2024). Synergistic impact of psoriasis and hypertension on all-cause mortality risk: A prospective cohort study. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0306048"},{"key":"ref_26","first-page":"152","article-title":"Increased glycoprotein acetylation is associated with high cardiac event rates: Analysis using coronary computed tomography angiography","volume":"20","author":"An","year":"2018","journal-title":"Anatol. J. Cardiol."},{"key":"ref_27","first-page":"7","article-title":"Serum High Sensitivity Cardiac Troponin I level and Its Relation to Severity of Psoriasis vulgaris","volume":"55","author":"Naby","year":"2026","journal-title":"Mansoura Med. J."},{"key":"ref_28","first-page":"e12865","article-title":"Can serum level of N-terminal pro B-type natriuretic peptide be used in patients with psoriasis as a predictor of cardiovascular disease?","volume":"32","author":"Niknezhad","year":"2019","journal-title":"Dermatol. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4103\/idoj.idoj_546_24","article-title":"Growth Differentiation Factor-15: One of the Missing Links between Psoriasis and Metabolic Syndrome","volume":"16","author":"Akl","year":"2025","journal-title":"Indian Dermatol. Online J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/ATVBAHA.118.312246","article-title":"Inflammasome Signaling and Impaired Vascular Health in Psoriasis","volume":"39","author":"Garshick","year":"2019","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Keermann, M., K\u00f5ks, S., Reimann, E., Prans, E., Abram, K., and Kingo, K. (2015). Transcriptional landscape of psoriasis identifies the involvement of IL36 and IL36RN. BMC Genom., 16.","DOI":"10.1186\/s12864-015-1508-2"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1016\/j.jid.2022.05.1085","article-title":"Association of S100A8\/A9 with Lipid-Rich Necrotic Core and Treatment with Biologic Therapy in Patients with Psoriasis: Results from an Observational Cohort Study","volume":"142","author":"Berg","year":"2022","journal-title":"J. Investig. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"378","DOI":"10.5021\/ad.2019.31.4.378","article-title":"Association between Homocysteine Levels and Psoriasis: A Meta-Analysis","volume":"31","author":"Kim","year":"2019","journal-title":"Ann. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/jdv.15211","article-title":"Role of galectin-3 in subclinical myocardial impairment in psoriasis","volume":"33","author":"Kotwica","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1038\/s41598-023-30103-2","article-title":"Quantitative proteomic analysis of human serum using tandem mass tags to predict cardiovascular risks in patients with psoriasis","volume":"13","author":"Kim","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"276","DOI":"10.5603\/CJ.a2017.0031","article-title":"Chemerin as a marker of subclinical cardiac involvement in psoriatic patients","volume":"24","author":"Aksu","year":"2017","journal-title":"Cardiol. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/bjd.12525","article-title":"Elevated serum levels of endocan in patients with psoriasis vulgaris: Correlations with cardiovascular risk and activity of disease","volume":"169","author":"Balta","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/MCA.0b013e328241d991","article-title":"Serum YKL-40 levels in patients with coronary artery disease","volume":"18","author":"Kucur","year":"2007","journal-title":"Coron. Artery Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5114\/dr.2026.163265","article-title":"Serum Chemerin Level as a Potential Biomarker of Early Cardiac Involvement in Patients with Psoriasis: A Case-Control Study","volume":"113","author":"Elradi","year":"2026","journal-title":"Dermatol. Rev."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Khatri, S., Suchday, P., Guddeti, A., Nanna, S., Gupta, S., Darapaneni, H., Mohammed, A.S., Desai, R., and Imtiaz, H. (2025). Endocan as a Novel Biomarker for Endothelial Dysfunction and Cardiovascular Prognosis in ST-Elevation Myocardial Infarction: A Contemporary Literature Review. J. Pers. Med., 16.","DOI":"10.3390\/jpm16010007"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cmet.2019.12.005","article-title":"Comprehensive Proteomics Analysis of Stressed Human Islets Identifies GDF15 as a Target for Type 1 Diabetes Intervention","volume":"31","author":"Nakayasu","year":"2020","journal-title":"Cell Metab."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"531","DOI":"10.5114\/ada.2019.89503","article-title":"Analysis of serum chemerin concentrations in psoriatic patients in relation to metabolic abnormalities","volume":"36","author":"Gerkowicz","year":"2019","journal-title":"Adv. Dermatol. Allergol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Li, J., Mao, C., Li, K., Huang, Y., Yang, Y., Li, K., Li, S., and Wen, L. (2026). Chemerin\/ChemerinR1 axis and inflammation-related diseases. Front. Mol. Biosci., 13.","DOI":"10.3389\/fmolb.2026.1785693"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11596-023-2721-x","article-title":"Chemerin Exacerbates Psoriasis by Stimulating Keratinocyte Proliferation and Cytokine Production","volume":"43","author":"Kong","year":"2023","journal-title":"Curr. Med. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1084\/jem.20030382","article-title":"Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids","volume":"198","author":"Wittamer","year":"2003","journal-title":"J. Exp. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bbrc.2012.05.103","article-title":"A novel adipocytokine, chemerin, exerts anti-inflammatory roles in human vascular endothelial cells","volume":"423","author":"Yamawaki","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Ferland, D.J., Garver, H., Contreras, G.A., Fink, G.D., and Watts, S.W. (2020). Chemerin contributes to in vivo adipogenesis in a location-specific manner. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0229251"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Zhao, L., Zhou, J., Abbasi, F., Fathzadeh, M., Knowles, J.W., Leung, L.L.K., and Morser, J. (2024). Chemerin in Participants with or without Insulin Resistance and Diabetes. Biomedicines, 12.","DOI":"10.3390\/biomedicines12040924"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000430343","article-title":"The Adipokine Chemerin Induces Apoptosis in Cardiomyocytes","volume":"37","author":"Varela","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"174566","DOI":"10.1016\/j.ejphar.2021.174566","article-title":"Chemerin-9 stimulates migration in rat cardiac fibroblasts in vitro","volume":"912","author":"Yamamoto","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref_51","first-page":"6756","article-title":"Aldosterone upregulates chemerin via chemokine-like receptor 1- Rho- ROCK- JNK signaling in cardiac fibroblasts","volume":"10","author":"Wang","year":"2017","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"H1851","DOI":"10.1152\/ajpheart.00285.2018","article-title":"Chemerin receptor blockade improves vascular function in diabetic obese mice via redox-sensitive and Akt-dependent pathways","volume":"315","author":"Neves","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1210\/jc.2010-0042","article-title":"Chemerin, a novel adipokine in the regulation of angiogenesis","volume":"95","author":"Bozaoglu","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s11010-020-04001-4","article-title":"Endocan, a novel inflammatory marker, is upregulated in human chondrocytes stimulated with IL-1 beta","volume":"476","author":"Scuruchi","year":"2021","journal-title":"Mol. Cell. Biochem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/path.4072","article-title":"Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGF\u03b22 in vascular abnormalization","volume":"228","author":"Dieterich","year":"2012","journal-title":"J. Pathol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/NEN.0b013e3181a52a7f","article-title":"Endocan expression and localization in human glioblastomas","volume":"68","author":"Maurage","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/sj.bjp.0705494","article-title":"Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells","volume":"140","author":"Gerritsen","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/glia.20247","article-title":"Transforming growth factor-beta-regulated gene transcription and protein expression in human GFAP-negative lamina cribrosa cells","volume":"52","author":"Kirwan","year":"2005","journal-title":"Glia"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.yexcr.2007.01.021","article-title":"Endocan is a VEGF-A and PI3K regulated gene with increased expression in human renal cancer","volume":"313","author":"Rennel","year":"2007","journal-title":"Exp. Cell Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1167\/iovs.04-0535","article-title":"Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth factor-\u03b2","volume":"45","author":"Zhao","year":"2004","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"20458","DOI":"10.1074\/jbc.271.34.20458","article-title":"ESM-1 is a novel human endothelial cell-specific molecule expressed in the lung and regulated by cytokines","volume":"271","author":"Lassalle","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00404-020-05520-7","article-title":"Endocan as a predictor of increased cardiovascular risk during the menopausal transition period","volume":"301","author":"Kaya","year":"2020","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1177\/0003319713513492","article-title":"Endocan--a novel inflammatory indicator in newly diagnosed patients with hypertension: A pilot study","volume":"65","author":"Balta","year":"2014","journal-title":"Angiology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/0003319717736158","article-title":"Endocan Concentration in Patients with Primary Hypertension","volume":"69","author":"Musialowska","year":"2018","journal-title":"Angiology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/JIM.0000000000000219","article-title":"Elevated Human Endothelial Cell-Specific Molecule-1 Level and Its Association with Coronary Artery Disease in Patients with Hypertension","volume":"63","author":"Xiong","year":"2015","journal-title":"J. Investig. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1089\/gtmb.2014.0274","article-title":"Serum endocan levels are correlated with the presence and severity of coronary artery disease in patients with hypertension","volume":"19","author":"Wang","year":"2015","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ancard.2018.04.023","article-title":"Biochemical markers of hypertension, prehypertension","volume":"67","author":"Turgunova","year":"2018","journal-title":"Ann. Cardiol. Angeiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1177\/0003319718823625","article-title":"The Relationship Between Serum Endocan Level and Aortic Elastic Properties in Patients with Newly Diagnosed Essential Hypertension","volume":"70","author":"Sivri","year":"2019","journal-title":"Angiology"},{"key":"ref_69","first-page":"76","article-title":"Is endocan a biochemical marker for asymptomatic target organ damage in hypertensive patients?","volume":"21","author":"Aksoy","year":"2019","journal-title":"Anatol. J. Cardiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/10641963.2019.1652632","article-title":"Serum endocan levels, carotid intima-media thickness and microalbuminuria in patients with newly diagnosed hypertension","volume":"41","author":"Oktar","year":"2019","journal-title":"Clin. Exp. Hypertens."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"9134096","DOI":"10.1155\/2019\/9134096","article-title":"Endocan Is an Independent Predictor of Heart Failure-Related Mortality and Hospitalizations in Patients with Chronic Stable Heart Failure","volume":"2019","author":"Kosir","year":"2019","journal-title":"Dis. Markers"},{"key":"ref_72","first-page":"114","article-title":"Endocan and resolvin-D1 association with ventricular dysfunction, lactic acidosis and prognostic scores in human acute heart failure","volume":"21","author":"Bessa","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1007\/s00380-020-01656-3","article-title":"Elevated plasma endocan and BOC in heart failure patients decrease after heart transplantation in association with improved hemodynamics","volume":"35","author":"Ahmed","year":"2020","journal-title":"Heart Vessel."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e13407","DOI":"10.1097\/MD.0000000000013407","article-title":"The higher serum endocan levels may be a risk factor for the onset of cardiovascular disease: A meta-analysis","volume":"97","author":"Zhao","year":"2018","journal-title":"Medicine"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/0003319714548870","article-title":"Serum Endocan Level and the Severity of Coronary Artery Disease: A Pilot Study","volume":"66","author":"Kose","year":"2015","journal-title":"Angiology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/0003319716646932","article-title":"Admission Endocan Level may be a Useful Predictor for In-Hospital Mortality and Coronary Severity Index in Patients with ST-Segment Elevation Myocardial Infarction","volume":"68","author":"Kundi","year":"2017","journal-title":"Angiology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cca.2020.07.041","article-title":"Endocan: A novel biomarker for risk stratification, prognosis and therapeutic monitoring in human cardiovascular and renal diseases","volume":"509","author":"Bessa","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11239-016-1424-6","article-title":"Endocan: A novel biomarker associated with well-developed coronary collateral circulation in patients with stable angina and chronic total occlusion","volume":"43","author":"Emet","year":"2017","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/0003319717703835","article-title":"Endocan Levels and Coronary Collateral Circulation in Stable Angina Pectoris: A Pilot Study","volume":"69","author":"Gok","year":"2018","journal-title":"Angiology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.amjms.2017.02.004","article-title":"The Association Between Endocan Levels and Subclinical Atherosclerosis in Patients with Type 2 Diabetes Mellitus","volume":"353","author":"Lv","year":"2017","journal-title":"Am. J. Med. Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1177\/0003319715616240","article-title":"Endocan Levels and Subclinical Atherosclerosis in Patients with Systemic Lupus Erythematosus","volume":"67","author":"Icli","year":"2016","journal-title":"Angiology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.2147\/COPD.S182731","article-title":"Serum endocan levels in patients with stable COPD","volume":"13","author":"Pihtili","year":"2018","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jaad.2013.09.013","article-title":"Serum endocan levels as a marker of disease activity in patients with Beh\u00e7et disease","volume":"70","author":"Balta","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0300-8932(10)70014-2","article-title":"Carotid intima-media thickness in subjects with no cardiovascular risk factors","volume":"63","author":"Jarauta","year":"2010","journal-title":"Rev. Esp. Cardiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/08037051.2014.972816","article-title":"Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: Comparative effects of amlodipine and valsartan","volume":"24","author":"Balta","year":"2015","journal-title":"Blood Press."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000350064","article-title":"The effects of arterial blood pressure reduction on endocan and soluble endothelial cell adhesion molecules (CAMs) and CAMs ligands expression in hypertensive patients on Ca-channel blocker therapy","volume":"37","author":"Tadzic","year":"2013","journal-title":"Kidney Blood Press. Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0167-4781(97)00122-X","article-title":"PLAB, a novel placental bone morphogenetic protein","volume":"1354","author":"Hromas","year":"1997","journal-title":"Biochim. Biophys. Acta."},{"key":"ref_88","first-page":"240","article-title":"Comparative effects of atorvastatin 80 mg and rosuvastatin 40 mg on the levels of serum endocan, chemerin, and galectin-3 in patients with acute myocardial infarction","volume":"22","author":"Altunkeser","year":"2019","journal-title":"Anatol. J. Cardiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ijbiomac.2019.09.235","article-title":"In-silico and in-vitro analysis of endocan interaction with statins","volume":"146","author":"Kumar","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","article-title":"MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily","volume":"94","author":"Bootcov","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0378-1119(97)00485-X","article-title":"Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta","volume":"203","author":"Lawton","year":"1997","journal-title":"Gene"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"bnaa007","DOI":"10.1210\/endrev\/bnaa007","article-title":"GDF15: A Hormone Conveying Somatic Distress to the Brain","volume":"41","author":"Lockhart","year":"2020","journal-title":"Endocr. Rev."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00424-020-02459-1","article-title":"GDF15, an update of the physiological and pathological roles it plays: A review","volume":"472","author":"Assadi","year":"2020","journal-title":"Pfl\u00fcgers Arch. Eur. J. Physiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pharmthera.2019.02.008","article-title":"Growth differentiation factor 15 (GDF15): A survival protein with therapeutic potential in metabolic diseases","volume":"198","author":"Baek","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"eaan2507","DOI":"10.1126\/science.aan2507","article-title":"A pathology atlas of the human cancer transcriptome","volume":"357","author":"Uhlen","year":"2017","journal-title":"Science"},{"key":"ref_96","first-page":"649","article-title":"NSAID activated gene (NAG-1), a modulator of tumorigenesis","volume":"39","author":"Eling","year":"2006","journal-title":"J. Biochem. Mol. Biol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"490842","DOI":"10.1155\/2015\/490842","article-title":"GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective","volume":"2015","author":"Adela","year":"2015","journal-title":"J. Diabetes Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/cen.14433","article-title":"Growth-differentiation-factor 15 levels in obese and healthy pregnancies: Relation to insulin resistance and insulin secretory function","volume":"95","author":"Joelsson","year":"2021","journal-title":"Clin. Endocrinol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0140-6736(03)15265-8","article-title":"Serum concentrations of macrophage inhibitory cytokine 1 (MIC 1) as a predictor of miscarriage","volume":"363","author":"Tong","year":"2004","journal-title":"Lancet"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/AOG.0b013e3182518fd3","article-title":"Diagnostic accuracy of maternal serum macrophage inhibitory cytokine-1 and pregnancy-associated plasma protein-A at 6\u201310 weeks of gestation to predict miscarriage","volume":"119","author":"Tong","year":"2012","journal-title":"Obstet. Gynecol."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Kaitu\u2019u-Lino, T.J., Bambang, K., Onwude, J., Hiscock, R., Konje, J., and Tong, S. (2013). Plasma MIC-1 and PAPP-a levels are decreased among women presenting to an early pregnancy assessment unit, have fetal viability confirmed but later miscarry. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0072437"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cyto.2016.05.002","article-title":"Serum levels of GDF15 are reduced in preeclampsia and the reduction is more profound in late-onset than early-onset cases","volume":"83","author":"Chen","year":"2016","journal-title":"Cytokine"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"107823","DOI":"10.1016\/j.diabres.2019.107823","article-title":"Serum growth differentiation factor 15 is associated with glucose metabolism in the third trimester in Chinese pregnant women","volume":"156","author":"Tang","year":"2019","journal-title":"Diabetes. Res. Clin. Pract."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s13340-020-00478-y","article-title":"A study of serum growth differentiation factor 15 in Indian women with and without gestational diabetes mellitus in the third trimester of pregnancy and its association with pro-inflammatory markers and glucose metabolism","volume":"12","author":"Banerjee","year":"2020","journal-title":"Diabetol. Int."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/jdi.13488","article-title":"Serum growth differentiation factor 15 is closely associated with metabolic abnormalities in Chinese pregnant women","volume":"12","author":"Li","year":"2021","journal-title":"J. Diabetes Investig."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/01.RES.0000202804.84885.d0","article-title":"GDF15\/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation","volume":"98","author":"Xu","year":"2006","journal-title":"Circ. Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/01.RES.0000202805.73038.48","article-title":"The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia\/reperfusion injury","volume":"98","author":"Kempf","year":"2006","journal-title":"Circ. Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"123093","DOI":"10.1016\/j.lfs.2024.123093","article-title":"Elevated serum GDF15 level as an early indicator of proximal tubular cell injury in acute kidney injury","volume":"357","author":"Sawasawa","year":"2024","journal-title":"Life Sci."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.cellsig.2012.03.014","article-title":"Macrophage inhibitory cytokine-1 stimulates proliferation of human umbilical vein endothelial cells by up-regulating cyclins D1 and E through the PI3K\/Akt-, ERK-, and JNK-dependent AP-1 and E2F activation signaling pathways","volume":"24","author":"Jin","year":"2012","journal-title":"Cell. Signal."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1007\/s11033-011-1182-7","article-title":"GDF-15 promotes angiogenesis through modulating p53\/HIF-1\u03b1 signaling pathway in hypoxic human umbilical vein endothelial cells","volume":"39","author":"Song","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2047-783X-18-19","article-title":"GDF-15 protects from macrophage accumulation in a mousemodel of advanced atherosclerosis","volume":"18","author":"Preusch","year":"2013","journal-title":"Eur. J. Med. Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1084\/jem.20100370","article-title":"Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis","volume":"208","author":"Bot","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1111\/bph.12736","article-title":"Olmesartan prevents cardiac rupture in mice with myocardial infarction by modulating growth differentiation factor 15 and p53","volume":"171","author":"Chen","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","article-title":"Cardiac Fibrosis: The Fibroblast Awakens","volume":"118","author":"Travers","year":"2016","journal-title":"Circ. Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.15252\/emmm.201707604","article-title":"GDF15 is a heart-derived hormone that regulates body growth","volume":"9","author":"Wang","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1161\/CIRCULATIONAHA.110.979740","article-title":"Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: The Rancho Bernardo Study","volume":"123","author":"Daniels","year":"2011","journal-title":"Circulation"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e008108","DOI":"10.1161\/JAHA.117.008108","article-title":"Protein Biomarkers of Cardiovascular Disease and Mortality in the Community","volume":"7","author":"Ho","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/eurheartj\/ehv491","article-title":"Growth differentiation factor-15 level predicts major bleeding cardiovascular events in patients with acute coronary syndromes: Results from the PLATO study","volume":"37","author":"James","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Tzikas, S., Palapies, L., Bakogiannis, C., Zeller, T., Sinning, C., Baldus, S., Bickel, C., Vassilikos, V., Lackner, K.J., and Zeiher, A. (2017). GDF-15 predicts cardiovascular events in acute chest pain patients. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0182314"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40119-019-0127-4","article-title":"Growth Differentiation Factor-15 Levels at Admission Provide Incremental Prognostic Information on All-Cause Long-term Mortality in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention","volume":"8","author":"Bodde","year":"2019","journal-title":"Cardiol. Ther."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1515\/cclm-2018-1189","article-title":"Acute-phase dynamics and prognostic value of growth differentiation factor-15 in ST-elevation myocardial infarction","volume":"57","author":"Rueda","year":"2019","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.amjcard.2011.05.028","article-title":"Relation of growth-differentiation factor 15 to left ventricular remodeling in ST-segment elevation myocardial infarction","volume":"108","author":"Avanzas","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e005580","DOI":"10.1161\/JAHA.117.005580","article-title":"Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated with Increased Risk of Major Bleeding","volume":"6","author":"Lindholm","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1373\/clinchem.2011.165720","article-title":"Emerging biomarkers in heart failure","volume":"58","author":"Januzzi","year":"2012","journal-title":"Clin. Chem."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3109\/1354750X.2015.1068856","article-title":"Candidate biomarkers in heart failure with reduced and preserved ejection fraction","volume":"20","author":"Sinning","year":"2015","journal-title":"Biomarkers"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ejhf.431","article-title":"Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction","volume":"18","author":"Chan","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/eurjhf\/hfs130","article-title":"Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction","volume":"14","author":"Santhanakrishnan","year":"2012","journal-title":"Eur. J. Heart Fail."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jchf.2017.07.013","article-title":"Utility of Growth Differentiation Factor-15, A Marker of Oxidative Stress and Inflammation, in Chronic Heart Failure: Insights From the HF-ACTION Study","volume":"5","author":"Sharma","year":"2017","journal-title":"JACC Heart Fail."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/clc.22844","article-title":"Growth differentiation factor 15 is associated with left atrial\/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation","volume":"41","author":"Hu","year":"2018","journal-title":"Clin. Cardiol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/S0140-6736(16)00741-8","article-title":"ARISTOTLE and RE-LY Investigators. The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: A derivation and validation study","volume":"387","author":"Hijazi","year":"2016","journal-title":"Lancet"},{"key":"ref_131","first-page":"184","article-title":"Role of GDF-15 as an inflammatory marker in patients with psoriasis vulgaris","volume":"55","author":"Erfan","year":"2021","journal-title":"Turkderm\u2014Turk. Arch. Dermatol. Venereol."},{"key":"ref_132","first-page":"593","article-title":"Investigating the Correlation between Growth Differentiation Factor 15 Serum Level and Its Gene Expression with Psoriasis and Its Severity","volume":"20","author":"Akbari","year":"2021","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"603","DOI":"10.17343\/sdutfd.1172484","article-title":"Could Growth Differentiation Factor-15 Be a New Inflammatory Pathway in Psoriasis Vulgaris?","volume":"29","author":"Korkmaz","year":"2022","journal-title":"Med. J. SDU"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/10408363.2019.1615034","article-title":"Growth differentiation factor 15: A novel biomarker with high clinical potential","volume":"56","author":"Desmedt","year":"2019","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"946","DOI":"10.5966\/sctm.2013-0055","article-title":"Concise review: Growth differentiation factor 15 in pathology: A clinical role?","volume":"2","author":"Corre","year":"2013","journal-title":"Stem Cells Transl. Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00109-011-0835-2","article-title":"Leukocyte integrin activation and deactivation: Novel mechanisms of balancing inflammation","volume":"90","author":"Zarbock","year":"2012","journal-title":"J. Mol. Med."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jid.2022.07.026","article-title":"Decreasing GDF15 Promotes Inflammatory Signals and Neutrophil Infiltration in Psoriasis Models","volume":"143","author":"Zhang","year":"2023","journal-title":"J. Investig. Dermatol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"e15316","DOI":"10.1111\/1756-185X.15316","article-title":"Evaluating the impact of growth differentiation factor 15 on the risk of psoriasis","volume":"27","author":"Jiang","year":"2024","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/jocd.14086","article-title":"The significance of endocan immunohistochemical expression in chronic plaque psoriasis","volume":"21","author":"Abdou","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/00033197251356576","article-title":"Endocan, a Potential Biomarker of Endothelial Dysfunction: A Brief Overview","volume":"77","author":"Bidlan","year":"2026","journal-title":"Angiology"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Chen, J., Jiang, L., Yu, X.H., Hu, M., Zhang, Y.K., Liu, X., He, P., and Ouyang, X. (2022). Endocan: A Key Player of Cardiovascular Disease. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.798699"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Wang, R., Tan, H., Li, Z., Li, D., Pan, Y., and He, Z. (2026). Immunomodulatory functions of growth differentiation factor 15 in skin aging and inflammatory dermatoses. Front. Immunol., 17.","DOI":"10.3389\/fimmu.2026.1902574"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4081\/reumatismo.2017.953","article-title":"Effects of secukinumab on serum adipocytokines: Preliminary data","volume":"69","author":"Fassio","year":"2017","journal-title":"Reumatismo"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8918\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:15:12Z","timestamp":1791605712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":143,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["ijms27198918"],"URL":"https:\/\/doi.org\/10.3390\/ijms27198918","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]}}}